These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 5446564

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Chlorthalidone--induced hypokalemia and abnormal carbohydrate metabolism.
    Chowdhury FR, Bleicher SJ.
    Horm Metab Res; 1970 Jan; 2(1):13-6. PubMed ID: 5520746
    [No Abstract] [Full Text] [Related]

  • 43. [COMPARISON OF THE HYPOTENSIVE EFFECTS OF RENESE (POLYTHIAZIDE) AND HYGROTON (CHLORTHALIDONE)].
    ROOTH G.
    Sven Lakartidn; 1963 Dec 27; 60():3927-31. PubMed ID: 14097090
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [Behavior of the insulin-, tolbutamide- and cortisone-tests depending on the age and body constitution of adult diabetics].
    Bojanowicz K, Stach A, Orzeszyna S.
    Z Gesamte Inn Med; 1971 Mar 01; 26(5):182-4. PubMed ID: 5560776
    [No Abstract] [Full Text] [Related]

  • 50. [ANTIHYPERTENSIVE PROPERTIES OF POLYTHIAZIDE].
    MONTANDON A.
    Ther Umsch; 1963 Dec 01; 20():564-6. PubMed ID: 14123133
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. [Value of diuretics in hypertension].
    Franz M, Hörl WH.
    Wien Med Wochenschr; 1996 Dec 01; 146(16):432-5. PubMed ID: 9036677
    [Abstract] [Full Text] [Related]

  • 53. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Black HR, Davis B, Barzilay J, Nwachuku C, Baimbridge C, Marginean H, Wright JT, Basile J, Wong ND, Whelton P, Dart RA, Thadani U, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Diabetes Care; 2008 Feb 01; 31(2):353-60. PubMed ID: 18000186
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. [Antihypertensive effect of metoprolol in essential hypertension].
    Rodríguez Rodríguez FJ, Petersen Guitarte G, Paumard Fraguas A, López-Vidriero E, Franco Manera R.
    Med Clin (Barc); 1983 Mar 12; 80(8):358-61. PubMed ID: 6855321
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.